ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.

Cedars Sinai Medical Center, Los Angeles.

Meeting: 2018 American Transplant Congress

Abstract number: B51

Keywords: Heart transplant patients, HLA antibodies, Outcome, Sensitization

Session Information

Date: Sunday, June 3, 2018

Session Name: Poster Session B: Heart and VADs: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • Effects of Anti-Human Leukocyte Antigen Antibody After Heart Transplantation
  • Primary Graft Dysfunction Post Heart Transplantation: Is There Greater Risk for De Novo Donor-Specific Antibody Development?

Purpose: Patients (pts) with prior transplants, blood transfusions, and pregnancies awaiting heart transplantation (HTx) have potential to develop circulating anti-HLA antibodies (HLA Abs). Pts at risk but who do not develop HLA Abs are termed “memory” type pts because they have the potential to mount an Ab response. Those pts with no HLA Abs detected and no risk factors are called “naïve” pts. Whether naïve vs memory vs detected HLA Ab pts have an increased risk for the development of donor-specific antibody (DSA) and/or rejection after the first yr has not been established.

Methods: Between 2010-15 we assessed 502 HTx pts and divided them into naïve (n=199), memory (n=156), and detected HLA Ab pts (n=147). Endpoints included 2-yr survival, development of DSA, 1-yr freedom from any-treated rejection (ATR), 1-year freedom from acute cellular rejection (ACR), 1-yr freedom from antibody mediated rejection (AMR), and 1-yr freedom from biopsy-negative rejection (BNR).

Results: There was no difference in 2-yr survival between the groups. Pts in the detected HLA Ab group had significantly reduced 2-yr freedom from development of DSA vs the naïve group (p<0.001). There was a strong trend towards reduced 2-yr freedom from DSA development in the memory group vs naïve pts (p=0.051). The detected HLA Ab group had a significantly reduced 1-yr freedom from AMR (p=0.003). There was no significant difference in ACR or BNR between the groups.

Conclusion: Memory pts and pts with detectable HLA Abs are at risk of developing DSA post-HTx. These pts may be considered for more intense immunosuppression to potentially reduce post-HTx DSA-related complications.

EndpointsNaive (n=199)Memory (n=156)Detectable anti-HLA (n=147)P-Value
2-Yr Survival86.4%87.3%89.6%0.660
2-Year Freedom from DSA Development92.4%84.3%*77.7%**0.001
1-Year Freedom from Any-Treated Rejection82.5%86.1%80.5%0.350
1-Year Freedom from ACR90.4%92.9%95.5%0.183
1-Year Freedom from AMR98.0%96.3%89.9%0.003
1-Year Freedom from BNR92.2%94.1%92.9%0.748
*p=0.051 in comparison to Naïve patients
**p<0.001 in comparison to Naïve patients

CITATION INFORMATION: Patel J., Kittleson M., Kransdorf E., Levine R., Dimbil S., Geft D., Chang D., Czer L., Kobashigawa J. Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Patel J, Kittleson M, Kransdorf E, Levine R, Dimbil S, Geft D, Chang D, Czer L, Kobashigawa J. Pre-Transplant Memory Patients Even without Detected Antibody Are at Rejection Risk in the First-Year after Heart Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/pre-transplant-memory-patients-even-without-detected-antibody-are-at-rejection-risk-in-the-first-year-after-heart-transplantation/. Accessed December 12, 2019.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Penis Transplantation: First U.S. Experience.
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Tacrolimus Dose and Trough Blood Levels in a US Liver Transplant Population
    • Penis Transplantation: First U.S. Experience.
    • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
    • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
    • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
    • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2019 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    wiley-new-logo

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.